-
-
-
-
-
-
-
Denali Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights
-
-
-
-
-
-
-
Denali Therapeutics Announces Closing of a $316 Million Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
-
-
-
-
-
-
Denali Therapeutics Announces Proposed Offering of Common Stock
-
-
-
-
-
-
-
Denali Therapeutics Announces Closing of Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
-
-
-
-
-
21,359 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

